Skip to content

Author

A. A. Moosavi-Movahedi

We have 2 of 60 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Mechanistic insights into the inhibition of insulin amyloidogenesis and associated toxicity by the p.M14L variant of exenatide.

Insulin fibrillation and the subsequent formation of toxic amyloid aggregates are significant challenges in therapeutic development and are associated with cellular proteotoxicity. In this research, we explored how the p.M14L exenatide variant affects the formation of insulin amyloid fibrils. Applying a combination of...

Zahra Bahrami, Mohammad Rajab Shalgahi, M. Shahsavani et al. · 0 citations
Open access Aug 2026

Cold stimulus during the fibrillation lag phase induces molecularly distinct amyloid strains

The results show how amyloid polymorphs could differentially modulate pathogenicity and the importance of environmental conditions on the molecular features of amyloid nucleation may be critical for design and stability of future protein biologics beyond therapeutic insulin.

Elnaz Hosseini, Saeid Hadi Alijanvand, Y. Kan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.